BCAB
Bioatla Inc
NASDAQ: BCAB · HEALTHCARE · BIOTECHNOLOGY
$4.21
+4.21% today
Updated 2026-04-30
Market cap
$8.07M
P/E ratio
—
P/S ratio
4.04x
EPS (TTM)
$-50.50
Dividend yield
—
52W range
$4 – $72
Volume
1.0M
Bioatla Inc (BCAB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |